These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis. Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S. Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247 [Abstract] [Full Text] [Related]
8. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates. Gillett MP, Obineche EN, Khan ST, Abdulle AM. Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187 [Abstract] [Full Text] [Related]
12. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Krane V, Krieter DH, Olschewski M, März W, Mann JF, Ritz E, Wanner C. Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429 [Abstract] [Full Text] [Related]
20. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial. Kerr PG, Sutherland WH, de Jong S, Vaithalingham I, Williams SM, Walker RJ. Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]